SEARCH

SEARCH BY CITATION

References

  • 1
    Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011;205:1018.
  • 2
    Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:2735.
  • 3
    Schanzer DL, Langley JM, Tam TWS. Influenza-attributed hospitalization rates among pregnant women in Canada 1994–2000. J Obstet Gynaecol Can 2007;29:6229.
  • 4
    Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. The Lancet. 2009;374:4518.
  • 5
    Martin A, Cox S, Jamieson DJ, Whiteman MK, Kulkarni A, Tepper NK. Respiratory illness hospitalizations among pregnant women during influenza season, 1998–2008. Matern Child Health J 2013;17:132531.
  • 6
    Dutkowski R. Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother 2010;65(Suppl. 2):ii1124.
  • 7
    Nicholson K, Aoki F, Osterhaus A, Trottier S, Carewicz O, Mercier C, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. The Lancet 2000;355:184550.
  • 8
    Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ [Internet]. 2009;339. Available from: [www.ncbi.nlm.nih.gov/pmc/articles/PMC2790574/]. Accessed 7 November 2012
  • 9
    Treanor JJHF. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000;283:101624.
  • 10
    Svensson T, Granath F, Stephansson O, Kieler H. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Pharmacoepidemiol Drug Saf 2011;20:10304.
  • 11
    Greer LG, Sheffield JS, Rogers VL, Roberts SW, McIntire DD, Wendel GD Jr. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 2010;115:71116.
  • 12
    Xie H, Yasseen AS III, Xie R, Fell DB, Sprague AE, Liu N, et al. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Am J Obstet Gynecol 2013;208:293.e17.
  • 13
    Saito S, Minakami H, Nakai A, Unno N, Kubo T, Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol 2013;209:130.e19.
  • 14
    Nieto-Pascual L, Arjona-Berral JE, Marín-Martín EM, Muñoz-Gomariz E, Ilich I, Castelo-Branco C. Early prophylactic treatment in pregnant women during the 2009–2010 H1N1 pandemic: obstetric and neonatal outcomes. J Obstet Gynaecol 2013;33:12834.
  • 15
    Lacroix I, Hurault C, Sarramon M, Guitard C, Berrebi A, Grau M, et al. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol 2009;65:83946.
  • 16
    Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:4929.
  • 17
    Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 1728.